Hikma Pharmaceutical - Publication of Offering Circular
Publication of Offering Circular
The Notes are expected to be admitted to trading on the
The Offering Circular is available for viewing.
To view the Offering Circular please paste the following URL into the address bar of your browser:
Enquiries and Investor Relations
EVP, Strategic Planning and Global Affairs
+44 (0) 20 7399 2760 / +44 7776 477050
Regulated Information Classification: Additional regulated information required to be disclosed under the laws of a Member State
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Offering Circular may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Offering Circular) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Offering Circular is not addressed. Prior to relying on the information contained in the Offering Circular, you must ascertain from the Offering Circular whether or not you are one of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
This information is provided by RNS, the news service of the
Quick facts: Hikma Pharmaceuticals PLC
Market Cap: £59.91 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE